Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Pyne, B. Kane, R. O‘Driscoll (United Kingdom). Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis. Eur Respir J 2010; 36: Suppl. 54, 4588

Member's Comments

No comment yet.

Related content which might interest you: Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005 Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Is nebulized saline a placebo in COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 184s Year: 2001 Inhalation therapy with hypertonic saline (3%) – A treatment option for airway disease in children? Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 Comparison of magnesium sulfate to normal saline as a vehicle for nebulized salbutamol in children with acute asthma; a clinical trial Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008 Success rate of sputum induction in the Leicester paediatric severe asthma clinic using nebulised hypertonic saline: A 2-year review Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010 Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining Year: 2011 Hyaluronic acid improves tolerability to 7% hypertonic saline solution in bronchiectasis patients Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Efficacy of hypertonic saline solution in infant with acute bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Inhaled hypertonic saline + hyaluronic acid (HSHA) and HS alone in patients with Cystic Fibrosis (CF): a 2 years retrospective analysis in Treviso’s CF Unit. Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 Nebulized 3% hypertonic saline in the treatment of acute bronchiolitis in infants Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Nebulised hypertonic saline in the treatment of viral bronchiolitis in infants Source: ISSN=ISSN 1810-6838, ISBN=, page=160 Year: 2007 Effects on the respirable dose < 3.3 µm of an isotonic DSCG inhalation solution (IsoCROM) comparing different nebuliser systems mimicking 3 year old childrens' breathing patterns Source: Eur Respir J 2007; 30: Suppl. 51, 460s Year: 2007 Effects of hypertonic saline on sputum clearance in patients with bronchiectasis Source: International Congress 2016 – Best abstracts on innovative outcomes and novel interventions in respiratory physiotherapy Year: 2016 Inhaled fraction and granulometry of hypertonic saline solution Aerosol for the ambulatory management of newborn babies with viral bronchiolitis: size matters. Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018 Efficacy of nasal wash with saline solution 2% NaCl in children with high nasal resistance Source: Eur Respir J 2001; 18: Suppl. 33, 120s Year: 2001